Skip to main content
. 2023 Dec 27;36(6):e101153. doi: 10.1136/gpsych-2023-101153

Table 1.

Baseline characteristics of patients with type 2 diabetes mellitus in the UK Biobank

Characteristics Total
(n=19 360)
Social isolation Loneliness
Least social isolation
(n=7409)
Moderate social isolation
(n=8147)
Most social isolation
(n=3804)
No loneliness
(n=17 873)
Loneliness
(n=1487)
Age, mean (SD), years 59.4 (7.0) 60.0 (6.9) 59.3 (7.1) 58.6 (7.1) 59.6 (7.0) 58.0 (7.2)
Gender, male, n (%) 11 820 (61.1) 4594 (62.0) 4811 (59.1) 2415 (63.5) 10 884 (60.9) 936 (62.9)
Ethnicity, white, n (%) 17 057 (88.1) 6587 (88.9) 7162 (87.9) 3308 (87.0) 15 746 (88.1) 1311 (88.2)
Assessment centre, n (%)
 England 17 237 (89.0) 6549 (88.4) 7295 (89.5) 3393 (89.2) 15 925 (89.1) 1312 (88.2)
 Scotland 1233 (6.4) 481 (6.5) 495 (6.1) 257 (6.8) 1124 (6.3) 109 (7.3)
 Wales 890 (4.6) 379 (5.1) 357 (4.4) 154 (4.0) 824 (4.6) 66 (4.4)
Currently employed, n (%) 8545 (44.1) 3135 (42.3) 3680 (45.2) 1730 (45.5) 7937 (44.4) 608 (40.9)
College or university degree, n (%) 4776 (24.7) 1888 (25.5) 1945 (23.9) 943 (24.8) 4485 (25.1) 291 (19.6)
Townsend Deprivation Index* −0.5 (3.4) −1.2 (3.1) −0.4 (3.4) 0.5 (3.6) −0.6 (3.3) 0.4 (3.6)
Current smokers, n (%) 2228 (11.5) 638 (8.6) 946 (11.6) 644 (16.9) 1974 (11.0) 254 (17.1)
Alcohol consumption status, n (%)
 Not current 2867 (14.8) 935 (12.6) 1222 (15.0) 710 (18.7) 2572 (14.4) 295 (19.8)
 Less than three times a week 10 545 (54.5) 3770 (50.9) 4552 (55.9) 2223 (58.4) 9713 (54.3) 832 (56.0)
 Three or more times a week 5948 (30.7) 2704 (36.5) 2373 (29.1) 871 (22.9) 5588 (31.3) 360 (24.2)
Physical activity (MET score), mean (SD) 9.6 (5.1) 10.3 (4.9) 9.5 (5.1) 8.8 (5.2) 9.7 (5.0) 8.7 (5.3)
TV watching time (hours/day), mean (SD) 3.4 (2.0) 3.3 (1.7) 3.5 (1.9) 3.8 (2.4) 3.4 (1.9) 4.0 (2.5)
Healthy diet score, median (IQR) 3 (2–4) 3 (2–4) 3 (2–4) 3 (2–3) 3 (2–4) 2 (2–3)
Sleep duration, n (%)
 Short (<7 hours/day) 5382 (27.8) 1754 (23.7) 2326 (28.6) 1302 (34.2) 4771 (26.7) 611 (41.1)
 Normal (7–8 hours/day) 11 719 (60.5) 4746 (64.1) 4893 (60.1) 2080 (54.7) 11 043 (61.8) 676 (45.5)
 Long (>8 hours/day) 2259 (11.7) 909 (12.3) 928 (11.4) 422 (11.1) 2059 (11.5) 200 (13.4)
Anxiety, n (%) 89 (0.5) 24 (0.3) 43 (0.5) 22 (0.6) 78 (0.4) 11 (0.7)
Depression, n (%) 296 (1.5) 66 (0.9) 135 (1.7) 95 (2.5) 240 (1.3) 56 (3.8)
Ever seeking help from physicians due to anxiety or depressive symptoms, n (%) 6797 (35.1) 2298 (31.0) 2954 (36.3) 1545 (40.6) 5982 (33.5) 815 (54.8)
Obesity status (kg/m2)
 Underweight or normal weight, n (%) 1893 (9.8) 713 (9.6) 812 (10.0) 368 (9.7) 1776 (9.9) 117 (7.9)
 Overweight, n (%) 6548 (33.8) 2697 (36.4) 2702 (33.2) 1149 (30.2) 6141 (34.4) 407 (27.4)
 Obese, n (%) 10 919 (56.4) 3999 (54.0) 4633 (56.9) 2287 (60.1) 9956 (55.7) 963 (64.8)
Grip strength (kg), mean (SD) 30.6 (11.1) 31.1 (11.1) 30.4 (11.0) 30.1 (11.0) 30.7 (11.0) 29.6 (11.2)
Systolic blood pressure (mm Hg), mean (SD) 145 (18) 145 (18) 145 (18) 144 (19) 145 (19) 142 (18)
Diastolic blood pressure (mm Hg), mean (SD) 83 (10) 83 (10) 83 (10) 83 (11) 83 (10) 83 (10)
Hyperlipidaemia, n (%) 13 265 (68.5) 5129 (69.2) 5558 (68.2) 2578 (67.8) 12 217 (68.4) 1048 (70.5)
Estimated glomerular filtration rate, mean (SD), mL/min/1.73 m2 89.8 (15.6) 89.5 (15.1) 90.0 (15.7) 90.3 (16.2) 89.7 (15.5) 91.2 (16.3)
Family history of diabetes, n (%) 7061 (36.5) 2690 (36.3) 3034 (37.2) 1337 (35.1) 6484 (36.3) 577 (38.8)
HbA1c, median (IQR), % 6.8 (6.2–7.5) 6.7 (6.1–7.4) 6.8 (6.2–7.5) 6.8 (6.2–7.7) 6.7 (6.2–7.5) 6.9 (6.2–7.7)
Diabetes duration, median (IQR), years 4.0 (1.0–8.0) 4.0 (1.0–8.0) 4.0 (1.0–8.0) 4.0 (1.0–8.0) 4.0 (1.0–8.0) 4.1 (1.0–9.0)
Diabetes medication use, n (%)
 Neither 7227 (37.3) 2877 (38.8) 3007 (36.9) 1343 (35.3) 6752 (37.8) 475 (31.9)
 Oral antidiabetic drug only 9584 (49.5) 3628 (49.0) 4036 (49.5) 1920 (50.5) 8822 (49.4) 762 (51.2)
 Insulin 2549 (13.2) 904 (12.2) 1104 (13.6) 541 (14.2) 2299 (12.9) 250 (16.8)
Chronic kidney disease, n (%) 328 (1.7) 107 (1.4) 141 (1.7) 80 (2.1) 298 (1.7) 30 (2.0)
Diabetes-related microvascular disease, n (%) 321 (1.7) 102 (1.4) 145 (1.8) 74 (1.9) 290 (1.6) 31 (2.1)
Neurodegenerative disease, n (%) 52 (0.3) 15 (0.2) 19 (0.2) 18 (0.5) 43 (0.2) 9 (0.6)
Respiratory disease, n (%) 717 (3.7) 227 (3.1) 301 (3.7) 189 (5.0) 627 (3.5) 90 (6.1)
Digestive disease, n (%) 269 (1.4) 78 (1.1) 118 (1.4) 73 (1.9) 243 (1.4) 26 (1.7)
Rheumatoid arthritis, n (%) 318 (1.6) 124 (1.7) 135 (1.7) 59 (1.6) 289 (1.6) 29 (2.0)
Osteoarthritis, n (%) 2130 (11.0) 774 (10.4) 882 (10.8) 474 (12.5) 1927 (10.8) 203 (13.7)

*Positive values of the index indicate areas with high material deprivation, whereas those with negative values indicate relative affluence.

HbA1c, haemoglobin A1c; IQR, interquartile range; MET, metabolic equivalent of task; SD, standard deviation.